J. J. J. van Giezen
AstraZeneca R&D Mölndal
Mölndal
Sweden
Name/email consistency: high
- Comparison of ticagrelor and thienopyridine P2Y(12) binding characteristics and antithrombotic and bleeding effects in rat and dog models of thrombosis/hemostasis. van Giezen, J.J., Berntsson, P., Zachrisson, H., Björkman, J.A. Thromb. Res. (2009)
- Ticagrelor binds to human P2Y(12) independently from ADP but antagonizes ADP-induced receptor signaling and platelet aggregation. VAN Giezen, J.J., Nilsson, L., Berntsson, P., Wissing, B.M., Giordanetto, F., Tomlinson, W., Greasley, P.J. J. Thromb. Haemost. (2009)
- Preclinical and clinical studies with selective reversible direct P2Y12 antagonists. van Giezen, J.J., Humphries, R.G. Semin. Thromb. Hemost. (2005)